T1	Participants 22 63	acute exacerbations of chronic bronchitis
T2	Participants 226 267	acute exacerbations of chronic bronchitis
T3	Participants 120 185	double-blind, randomized, placebo-controlled trial in 40 patients
T4	Participants 1015 1079	moderately ill patients with exacerbations of chronic bronchitis
T5	Participants 269 411	All patients were sufficiently ill to require hospitalization although none needed ventilatory support; the presence of pneumonia was excluded
